Subscribe
official_portrait_of_michelle_donelan_mp
(Photo source UK Parliament website. Used under Creative Commons).
7 September 2023FeaturesBig PharmaSarah Speight

‘One of the most positive announcements since Brexit’: UK lawyers react to new Horizon funding deal

Today, the British scientific community woke to the news that the UK has finally rejoined Horizon Europe, the European Union’s €95.5 billion ($102 billion) research funding programme.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Horizon crosses the Atlantic to acquire Raptor for $800m
14 September 2016   Irish drugs producer Horizon Pharma has entered into a definitive agreement with Raptor Pharmaceuticals in which Horizon will buy the US biopharmaceutical company for $800 million.
Americas
Horizon agrees licensing deal over anti-inflammatory drug
18 September 2015   Drugs company Horizon Pharma has agreed to settle a patent dispute centring on a proposed generic version of its anti-inflammatory drug Pennsaid.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Horizon crosses the Atlantic to acquire Raptor for $800m
14 September 2016   Irish drugs producer Horizon Pharma has entered into a definitive agreement with Raptor Pharmaceuticals in which Horizon will buy the US biopharmaceutical company for $800 million.
Americas
Horizon agrees licensing deal over anti-inflammatory drug
18 September 2015   Drugs company Horizon Pharma has agreed to settle a patent dispute centring on a proposed generic version of its anti-inflammatory drug Pennsaid.

More on this story

Americas
Horizon crosses the Atlantic to acquire Raptor for $800m
14 September 2016   Irish drugs producer Horizon Pharma has entered into a definitive agreement with Raptor Pharmaceuticals in which Horizon will buy the US biopharmaceutical company for $800 million.
Americas
Horizon agrees licensing deal over anti-inflammatory drug
18 September 2015   Drugs company Horizon Pharma has agreed to settle a patent dispute centring on a proposed generic version of its anti-inflammatory drug Pennsaid.

More features

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
GSK triumphs in EPO appeal, revoking Pfizer patent
Teva fights for re-listing of inhaler patents at US appeals court
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
Teva faces $500m fine for antitrust breaches over MS drug